Related Experiment Video
Updated: Aug 19, 2026
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
[Relation between clinical presentation and prognosis of patients with papillary thyroid microcarcinoma]
Sergio Ortiz1, José Manuel Rodríguez, Nuria Torregrosa
1Servicio de Cirugía General y Aparato Digestivo I. Hospital Universitario Virgen de la Arrixaca. Murcia. España.
Background And Objective:
We aimed to analyze patients with papillary thyroid microcarcinoma (PTM) in order to establish the prognosis according to the differences observed between those diagnosed before surgery and those diagnosed postoperatively.
Patients And Method:
Retrospective study of 83 PTM patients who were distributed in 2 groups. Clinical, histological and follow-up data were compared. Survival and disease-free interval (DFI) were analyzed in both groups.
Results:
Group A (diagnosed before surgery): 30 patients (36.1%); group B (diagnosed postoperatively): 53 patients (63.9%). Five group A patients had a relapse. Overall survival was 98.8% and overall DFI was 94% (83.3% in group A and 100% in group B, p = 0.01).
Conclusions:
It is useful to differentiate patients with PTM diagnosed before surgery from those whose PTM was diagnosed after since their evolution is different.
